Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
一项多中心、为期 12 周、随机、双盲、安慰剂对照、平行组、研究者发起的试验的理论依据和设计,旨在研究 elobixibat 治疗慢性便秘的疗效和安全性。
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2021-060704
Tanaka, Kosuke; Kessoku, Takaomi; Yamamoto, Atsushi; Takahashi, Kota; Kasai, Yuki; Ozaki, Anna; Iwaki, Michihiro; Kobayashi, Takashi; Yoshihara, Tsutomu; Misawa, Noboru; Kato, Takayuki; Arimoto, Jun; Fuyuki, Akiko; Sakai, Eiji; Higurashi, Takuma; Chiba, Hideyuki; Hosono, Kunihiro; Yoneda, Masato; Iwasaki, Tomoyuki; Kurihashi, Takeo; Nakatogawa, Machiko; Suzuki, Ayao; Taguri, Masataka; Oyamada, Shunsuke; Ariyoshi, Keisuke; Kobayashi, Noritoshi; Ichikawa, Yasushi; Nakajima, Atsushi